The growing importance of biosimilars to the global off-patent industry is highlighted in the third and final part of Generics Bulletin’s annual Top 50 ranking of the world’s leading generics and biosimilars players.
Following Celltrion’s leap from 30th to 25th in the second section of this year’s Top 50 (Also see "Ups And Downs See Mid-Table Players Shift Position" - Generics Bulletin, 10 August, 2021
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?